Abstract
Recent data suggest that women obtain greater benefit than men from IV fibrinolysis for acute ischemic stroke. It is unknown whether this gender-thrombolysis advantage extends to those treated with intra-arterial (IA) thrombolysis. The authors evaluated the independent effect of gender among ischemic stroke patients treated with IA fibrinolysis and found no differences in short-term clinical and angiographic outcomes between men and women who received IA thrombolysis for acute ischemic stroke.
MeSH terms
-
Aged
-
Brain Ischemia / drug therapy*
-
Brain Ischemia / epidemiology*
-
Comorbidity
-
Female
-
Fibrinolytic Agents / administration & dosage*
-
Humans
-
Infusions, Intra-Arterial
-
Male
-
Outcome Assessment, Health Care / methods*
-
Prognosis
-
Retrospective Studies
-
Risk Assessment
-
Risk Factors
-
Sex Factors
-
Stroke / drug therapy*
-
Stroke / epidemiology*
-
Thrombolytic Therapy / statistics & numerical data*
-
Tissue Plasminogen Activator / administration & dosage
-
Treatment Outcome
-
United States / epidemiology
-
Urokinase-Type Plasminogen Activator / administration & dosage
Substances
-
Fibrinolytic Agents
-
Tissue Plasminogen Activator
-
Urokinase-Type Plasminogen Activator